|
Our partnership with Progenitor Cell Therapy, LLC provides Amorcyte, Inc. access to a company with a very successful record of cGMP cell therapy manufacturing, accredited by the Foundation for the Accreditation of Cell Therapies (FACT). The ability to leverage PCT’s process development and core cell therapy expertise will provide a reasonable cost basis for AMR-001 manufacturing.
PCT has agreed to provide cell processing services on an exclusive basis from its two cell therapy laboratories in Hackensack, NJ and Mountain View, CA. PCT laboratories comply with the FDA’s current Good Manufacturing Practices (cGMP) guidelines and the standards of the American Association of Blood Banks (AABB).
This strategic relationship allows Amorcyte to pursue other related potential product development opportunities.
|
